Physician profile
Omar E Beidas
NPI 1184919102
$29,405.26
in general payments reported to CMS, 2019-2025
15 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $162 · 2021: $117 · 2022: $7,260 · 2023: $2,235 · 2024: $8,169 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Honoraria: $6,275 · Food and Beverage: $2,390 · Travel and Lodging: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,587.50 |
| Honoraria | $6,275.00 |
| Food and Beverage | $2,390.21 |
| Travel and Lodging | $1,373.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $11,681.70 | 2024-2025 | Galaflex, Phasix Mesh |
| Surgical Innovation Associates, INC. | $6,000.00 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $5,437.50 | 2024-2025 | |
| Integra Lifesciences Corporation | $1,754.74 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Musculoskeletal Transplant Foundation INC. | $1,520.01 | 2023 | |
| Medtronic, INC. | $1,080.00 | 2022 | |
| Mentor Worldwide LLC | $635.40 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $258.26 | 2023-2025 | |
| Sientra, INC. | $254.24 | 2019-2022 | |
| Motiva USA, LLC | $165.03 | 2025 | |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Allergan, INC. | $143.04 | 2019-2021 | |
| Bsn Medical INC | $138.50 | 2022-2024 | |
| Polarityte, INC. | $102.57 | 2021 | |
| Philips North America LLC | $84.27 | 2025 | Azurion 5 M20 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Beidas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.